NeuPath Health Inc

Research NeuPath Health Inc (NPTH) on Bullrun: valuation model: 37.1% overvalued, market cap CAD 34.27M, P/E 61.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNPTH
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyCAD
• Valuation signal37.1% overvalued
• Market capCAD 34.27M
• P/E61.0
• Financial periodQ4 2025
• RevenueCAD 22.15M
• Net income-CAD 409.00K
• Free cash flowCAD 417.00K
• Gross margin18.3%

Valuation Snapshot

Bullrun's latest valuation model marks NeuPath Health Inc as 37.1% overvalued; latest market cap is CAD 34.27M; P/E is 61.0.

About NeuPath Health Inc

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

Frequently asked questions

Is NeuPath Health Inc overvalued or undervalued?

Bullrun's valuation model currently marks NeuPath Health Inc as 37.1% overvalued.

What is NeuPath Health Inc's market cap?

NeuPath Health Inc's market capitalization is CAD 34.27M.

What is NeuPath Health Inc's P/E ratio?

NeuPath Health Inc's price-to-earnings (P/E) ratio is 61.0.

What does NeuPath Health Inc do?

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.